Article
Tax Compliance For Chinese Individuals Investing Overseas (Part II): Beyond CRS, The Beneficial Ownership Regime As A Parallel Transparency Framework
11 September 2026
China · Tax
Han Kun Law Offices
China
Thought Leadership
Article
Client Alert: Provisions Of The State Council On Outbound Investment
11 September 2026
China · International Law
Article
Ten Minefields: A Guide To Avoiding Pitfalls In Applying For Human Genetic Resources Projects In China
03 December 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
China Released Draft Medical Device Law For Comments
03 December 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
汉坤 • 观点 | 《药品管理法实施条例》（修订草案）重点快评
15 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
汉坤 • 观点 | 中国药品年度报告制度简析
15 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
汉坤 • 观点 | 简评新版《医疗器械临床试验质量管理规范（GCP）》
15 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Compliance Highlights And Strategies In High-Risk Clinical Research Landscape
14 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Han Kun • Opinion | Hot Spot Tracking: Daily Regulatory Risk Warnings For Drug Clinical Trial Institutions
14 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Achievements Of Our Country's Drug Review And Approval System Reform (Part 1)
14 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Han Kun • Opinion | Settle The Dust Or Let The Bullets Fly: Biden Administration Signs Executive Order On Promoting Biotechnology And Biomanufacturing Innovation
14 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Han Kun • Opinion | Interpretation Of The "Detailed Rules For The Supervision Of Internet Diagnosis And Treatment (Trial)"
13 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Han Kun • Opinion | Finally Waiting For You - Interpreting The New Policy Of Cross-border Contract Production Of Drugs And Medical Devices In The Guangdong-Hong Kong-Macao Greater Bay Area
13 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Han Kun • Opinion | Research On Urban Customized Commercial Medical Insurance
13 October 2025
China · Insurance
Article
Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Reform Of Our Country's Drug Review And Approval System (Part II)
09 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Reform Achievements Of Our Country's Drug Review And Approval System (Part II)
09 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
汉坤 • 观点 | 医药BD项目如何友好"分手"？
09 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
How Digital Therapeutics (DTx) Products Are Regulated In China?
09 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
生命科学行业License-in/out合同争议要点分析（三）：不竞争条款
09 October 2025
China · Food, Drugs, Healthcare, Life Sciences
Article
2024 Data Analytics: China Life Sciences NewCo & Licensing Terms
09 October 2025
China · Food, Drugs, Healthcare, Life Sciences